{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T03:08:15Z","timestamp":1777950495653,"version":"3.51.4"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T00:00:00Z","timestamp":1689206400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.biopha.2023.115171","type":"journal-article","created":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T06:12:48Z","timestamp":1690179168000},"page":"115171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["N6-methyladenosine modification: an important player in the tumor immune microenvironment"],"prefix":"10.1016","volume":"165","author":[{"given":"Jiaxiang","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2023.115171_bib1","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nature11112","article-title":"Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq","volume":"485","author":"Dominissini","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2023.115171_bib2","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41571-021-00514-z","article-title":"Planning for tomorrow: global cancer incidence and the role of prevention 2020-2070","volume":"18","author":"Soerjomataram","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biopha.2023.115171_bib3","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1093\/annonc\/mdw168","article-title":"Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy","volume":"27","author":"Pitt","year":"2016","journal-title":"Ann. Oncol.: Off. J. Eur. Soc. Med. Oncol."},{"key":"10.1016\/j.biopha.2023.115171_bib4","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/s41577-021-00541-y","article-title":"Metabolic barriers to cancer immunotherapy","volume":"21","author":"DePeaux","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2023.115171_bib5","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1158\/2159-8290.CD-20-0805","article-title":"Fueling the fire: inflammatory forms of cell death and implications for cancer immunotherapy","volume":"11","author":"Rosenbaum","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.biopha.2023.115171_bib6","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2023.115171_bib7","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1039\/C6CS00599C","article-title":"Epigenetic modification of nucleic acids: from basic studies to medical applications","volume":"46","author":"Chen","year":"2017","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.biopha.2023.115171_bib8","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s41573-020-0077-5","article-title":"Targeting the epigenetic regulation of antitumour immunity","volume":"19","author":"Hogg","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2023.115171_bib9","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41568-020-0253-2","article-title":"Role of RNA modifications in cancer","volume":"20","author":"Barbieri","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2023.115171_bib10","article-title":"The potential role of m6A modifications on immune cells and immunotherapy","volume":"160","author":"Gan","year":"2023","journal-title":"Biomed. Pharmacother. = Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2023.115171_bib11","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12943-022-01500-4","article-title":"The role of m6A RNA methylation in cancer metabolism","volume":"21","author":"An","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2023.115171_bib12","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12943-019-1109-9","article-title":"Functions of N6-methyladenosine and its role in cancer","volume":"18","author":"He","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2023.115171_bib13","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12943-021-01447-y","article-title":"METTL3\/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N(6)-methyladenosine modification of PD-L1 mRNA in breast cancer","volume":"21","author":"Wan","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2023.115171_bib14","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12943-021-01398-4","article-title":"N(6)-methyladenosine-modified circIGF2BP3 inhibits CD8(+) T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer","volume":"20","author":"Liu","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2023.115171_bib15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13045-021-01129-8","article-title":"N6-methyladenosine methyltransferases: functions, regulation, and clinical potential","volume":"14","author":"Huang","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.biopha.2023.115171_bib16","doi-asserted-by":"crossref","first-page":"8619275","DOI":"10.1155\/2022\/8619275","article-title":"Delicaflavone represses lung cancer growth by activating antitumor immune response through N6-methyladenosine transferases and oxidative stress","volume":"2022","author":"Wang","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.biopha.2023.115171_bib17","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/nature24678","article-title":"Promoter-bound METTL3 maintains myeloid leukaemia by m(6)A-dependent translation control","volume":"552","author":"Barbieri","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2023.115171_bib18","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nchembio.687","article-title":"N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO","volume":"7","author":"Jia","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.biopha.2023.115171_bib19","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.cell.2012.05.003","article-title":"Comprehensive analysis of mRNA methylation reveals enrichment in 3\u2032 UTRs and near stop codons","volume":"149","author":"Meyer","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2023.115171_bib20","article-title":"N(6) -methyladenosine-modified CBX1 regulates nasopharyngeal carcinoma progression through heterochromatin formation and STAT1 activation","volume":"9","author":"Zhao","year":"2022","journal-title":"Adv. Sci. (Weinheim, Baden-Wurttemberg, Germany)"},{"key":"10.1016\/j.biopha.2023.115171_bib21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrm.2016.132","article-title":"Post-transcriptional gene regulation by mRNA modifications","volume":"18","author":"Zhao","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2023.115171_bib22","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s41392-022-01003-0","article-title":"Role of main RNA modifications in cancer: N(6)-methyladenosine, 5-methylcytosine, and pseudouridine","volume":"7","author":"Xue","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.biopha.2023.115171_bib23","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1101\/gad.309146.117","article-title":"Zc3h13\/Flacc is required for adenosine methylation by bridging the mRNA-binding factor Rbm15\/Spenito to the m(6)A machinery component Wtap\/Fl(2)d","volume":"32","author":"Knuckles","year":"2018","journal-title":"Genes Dev."},{"key":"10.1016\/j.biopha.2023.115171_bib24","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nchembio.1432","article-title":"A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation","volume":"10","author":"Liu","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.biopha.2023.115171_bib25","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.celrep.2014.05.048","article-title":"Perturbation of m6A writers reveals two distinct classes of mRNA methylation at internal and 5\u2032 sites","volume":"8","author":"Schwartz","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.biopha.2023.115171_bib26","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","article-title":"The role of m6A modification in the biological functions and diseases","volume":"6","author":"Jiang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.biopha.2023.115171_bib27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41422-018-0113-8","article-title":"A novel m(6)A reader Prrc2a controls oligodendroglial specification and myelination","volume":"29","author":"Wu","year":"2019","journal-title":"Cell Res."},{"key":"10.1016\/j.biopha.2023.115171_bib28","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/cr.2017.10","article-title":"Cytoplasmic m(6)A reader YTHDF3 promotes mRNA translation","volume":"27","author":"Li","year":"2017","journal-title":"Cell Res."},{"key":"10.1016\/j.biopha.2023.115171_bib29","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41421-018-0019-0","article-title":"VIRMA mediates preferential m(6)A mRNA methylation in 3\u2032UTR and near stop codon and associates with alternative polyadenylation","volume":"4","author":"Yue","year":"2018","journal-title":"Cell Discov."},{"key":"10.1016\/j.biopha.2023.115171_bib30","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/jmcb\/mjz085","article-title":"Marking RNA: m6A writers, readers, and functions in Arabidopsis","volume":"11","author":"Reichel","year":"2019","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2023.115171_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202106558","article-title":"Glutathione-bioimprinted nanoparticles targeting of N6-methyladenosine FTO demethylase as a strategy against leukemic stem cells","volume":"18","author":"Cao","year":"2022","journal-title":"Small (Weinheim an der Bergstrasse, Germany)"},{"key":"10.1016\/j.biopha.2023.115171_bib32","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/nature08921","article-title":"Crystal structure of the FTO protein reveals basis for its substrate specificity","volume":"464","author":"Han","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2023.115171_bib33","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.molcel.2012.10.015","article-title":"ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility","volume":"49","author":"Zheng","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.biopha.2023.115171_bib34","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature12730","article-title":"N6-methyladenosine-dependent regulation of messenger RNA stability","volume":"505","author":"Wang","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2023.115171_bib35","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","article-title":"Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation","volume":"20","author":"Huang","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.biopha.2023.115171_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.789","article-title":"METTL3 enhances the effect of YTHDF1 on NEDD1 mRNA stability by m6A modification in diffuse large B-cell lymphoma cells","volume":"11","author":"Feng","year":"2023","journal-title":"Immun. Inflamm. Dis."},{"key":"10.1016\/j.biopha.2023.115171_bib37","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1007\/s13577-022-00769-3","article-title":"METTL3 promotes m6A hypermethylation of RBM14 via YTHDF1 leading to the progression of hepatocellular carcinoma","volume":"35","author":"Hu","year":"2022","journal-title":"Hum. Cell"},{"key":"10.1016\/j.biopha.2023.115171_bib38","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.celrep.2018.03.077","article-title":"Molecular characterization and clinical relevance of metabolic expression subtypes in human cancers","volume":"23","author":"Peng","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.biopha.2023.115171_bib39","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ni.3830","article-title":"The RNA helicase DDX46 inhibits innate immunity by entrapping m(6)A-demethylated antiviral transcripts in the nucleus","volume":"18","author":"Zheng","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biopha.2023.115171_bib40","doi-asserted-by":"crossref","first-page":"C762","DOI":"10.1152\/ajpcell.00212.2019","article-title":"The N(6)-methyladenosine (m(6)A)-forming enzyme METTL3 facilitates M1 macrophage polarization through the methylation of STAT1 mRNA","volume":"317","author":"Liu","year":"2019","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.biopha.2023.115171_bib41","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","article-title":"Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA","volume":"23","author":"Karik\u00f3","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2023.115171_bib42","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA: Cancer J. Clin."},{"key":"10.1016\/j.biopha.2023.115171_bib43","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA: a Cancer J. Clin."},{"key":"10.1016\/j.biopha.2023.115171_bib44","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet (Lond., Engl.)"},{"key":"10.1016\/j.biopha.2023.115171_bib45","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular carcinoma","volume":"380","author":"Villanueva","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2023.115171_bib46","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41571-021-00573-2","article-title":"Immunotherapies for hepatocellular carcinoma","volume":"19","author":"Llovet","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biopha.2023.115171_bib47","doi-asserted-by":"crossref","first-page":"5001","DOI":"10.7150\/ijbs.70149","article-title":"ALKBH5\/MAP3K8 axis regulates PD-L1+ macrophage infiltration and promotes hepatocellular carcinoma progression","volume":"18","author":"You","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.biopha.2023.115171_bib48","doi-asserted-by":"crossref","first-page":"1144774","DOI":"10.3389\/fimmu.2023.1144774","article-title":"LRPPRC facilitates tumor progression and immune evasion through upregulation of m(6)A modification of PD-L1 mRNA in hepatocellular carcinoma","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2023.115171_bib49","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1021\/acscentsci.2c00107","article-title":"Allosteric regulation of IGF2BP1 as a novel strategy for the activation of tumor immune microenvironment","volume":"8","author":"Liu","year":"2022","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.biopha.2023.115171_bib50","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12943-023-01759-1","article-title":"Exosome-derived circCCAR1 promotes CD8\u2009+\u2009T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma","volume":"22","author":"Hu","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2023.115171_bib51","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","article-title":"Colorectal cancer","volume":"394","author":"Dekker","year":"2019","journal-title":"Lancet (Lond., Engl.)"},{"key":"10.1016\/j.biopha.2023.115171_bib52","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMra2200869","article-title":"Increasing incidence of early-onset colorectal cancer","volume":"386","author":"Sinicrope","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2023.115171_bib53","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S2468-1253(21)00426-X","article-title":"The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection","volume":"7","author":"Patel","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2023.115171_bib54","first-page":"372","article-title":"Clinical management of metastatic colorectal cancer in the era of precision medicine","volume":"72","author":"Ciardiello","year":"2022","journal-title":"CA: Cancer J. Clin."},{"key":"10.1016\/j.biopha.2023.115171_bib55","first-page":"n1855","article-title":"Screening and prevention of colorectal cancer","volume":"374","author":"Kanth","year":"2021","journal-title":"BMJ (Clin. Res. Ed. )"},{"key":"10.1016\/j.biopha.2023.115171_bib56","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1053\/j.gastro.2022.06.024","article-title":"METTL3 inhibits antitumor immunity by targeting m(6)A-BHLHE41-CXCL1\/CXCR2 axis to promote colorectal cancer","volume":"163","author":"Chen","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2023.115171_bib57","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020104514","article-title":"m(6) A RNA methyltransferases METTL3\/14 regulate immune responses to anti-PD-1 therapy","volume":"39","author":"Wang","year":"2020","journal-title":"EMBO J."},{"key":"10.1016\/j.biopha.2023.115171_bib58","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2022-328845","article-title":"Targeting m(6)A reader YTHDF1 augments antitumour immunity and boosts anti-PD-1 efficacy in colorectal cancer","author":"Bao","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.biopha.2023.115171_bib59","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.molcel.2022.02.033","article-title":"Lactylation-driven METTL3-mediated RNA m(6)A modification promotes immunosuppression of tumor-infiltrating myeloid cells","volume":"82","author":"Xiong","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.biopha.2023.115171_bib60","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.ccell.2021.04.016","article-title":"The loss of RNA N(6)-adenosine methyltransferase Mettl14 in tumor-associated macrophages promotes CD8(+) T cell dysfunction and tumor growth","volume":"39","author":"Dong","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biopha.2023.115171_bib61","doi-asserted-by":"crossref","DOI":"10.1038\/s41568-023-00565-7","article-title":"The journey from melanocytes to melanoma","author":"Centeno","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2023.115171_bib62","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41568-022-00442-9","article-title":"Mechanisms of immune activation and regulation: lessons from melanoma","volume":"22","author":"Kalaora","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"Suppl 2","key":"10.1016\/j.biopha.2023.115171_bib63","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/jdv.15307","article-title":"Association of sunbed use with skin cancer risk factors in Europe: an investigation within the Euromelanoma skin cancer prevention campaign","volume":"33","author":"Suppa","year":"2019","journal-title":"J. Eur. Acad. Dermatol. Venereol.: JEADV"},{"key":"10.1016\/j.biopha.2023.115171_bib64","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1093\/jnci\/djab131","article-title":"Annual Report to the Nation on the Status of Cancer, Part 1: National Cancer Statistics","volume":"113","author":"Islami","year":"2021","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.biopha.2023.115171_bib65","doi-asserted-by":"crossref","first-page":"20159","DOI":"10.1073\/pnas.1918986117","article-title":"ALKBH5 regulates anti-PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment","volume":"117","author":"Li","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2023.115171_bib66","doi-asserted-by":"crossref","first-page":"5522","DOI":"10.1038\/s41467-021-25803-0","article-title":"METTL3-mediated m(6)A RNA methylation promotes the anti-tumour immunity of natural killer cells","volume":"12","author":"Song","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2023.115171_bib67","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/s41467-021-21514-8","article-title":"RNA m6A methylation orchestrates cancer growth and metastasis via macrophage reprogramming","volume":"12","author":"Yin","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2023.115171_bib68","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-019-0916-x","article-title":"Anti-tumour immunity controlled through mRNA m(6)A methylation and YTHDF1 in dendritic cells","volume":"566","author":"Han","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2023.115171_bib69","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(21)00312-3","article-title":"Lung cancer","volume":"398","author":"Thai","year":"2021","journal-title":"Lancet (Lond., Engl.)"},{"key":"10.1016\/j.biopha.2023.115171_bib70","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/cac2.12359","article-title":"Non-small cell lung cancer in China","volume":"42","author":"Chen","year":"2022","journal-title":"Cancer Commun. (Lond., Engl.)"},{"key":"10.1016\/j.biopha.2023.115171_bib71","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41572-020-00235-0","article-title":"Small-cell lung cancer","volume":"7","author":"Rudin","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.biopha.2023.115171_bib72","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1200\/JCO.21.01626","article-title":"Targeted therapies for lung cancer patients with oncogenic driver molecular alterations","volume":"40","author":"Tan","year":"2022","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.biopha.2023.115171_bib73","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1200\/JCO.21.01497","article-title":"First-line immunotherapy for non-small-cell lung cancer","volume":"40","author":"Reck","year":"2022","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.biopha.2023.115171_bib74","doi-asserted-by":"crossref","first-page":"1962656","DOI":"10.1080\/2162402X.2021.1962656","article-title":"YTHDF1 and YTHDF2 are associated with better patient survival and an inflamed tumor-immune microenvironment in non-small-cell lung cancer","volume":"10","author":"Tsuchiya","year":"2021","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.biopha.2023.115171_bib75","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41467-020-20527-z","article-title":"circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunity","volume":"12","author":"Li","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2023.115171_bib76","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.cmet.2021.04.001","article-title":"Tumors exploit FTO-mediated regulation of glycolytic metabolism to evade immune surveillance","volume":"33","author":"Liu","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.biopha.2023.115171_bib77","article-title":"The m6A reader YTHDF2 promotes bladder cancer progression by suppressing RIG-I-mediated immune response","author":"Zhang","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2023.115171_bib78","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.1158\/0008-5472.CAN-21-0468","article-title":"M(6)A demethylase ALKBH5 regulates PD-L1 expression and tumor immunoenvironment in intrahepatic cholangiocarcinoma","volume":"81","author":"Qiu","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2023.115171_bib79","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003663","article-title":"Loss of YTHDF1 in gastric tumors restores sensitivity to antitumor immunity by recruiting mature dendritic cells","volume":"10","author":"Bai","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.biopha.2023.115171_bib80","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12943-022-01572-2","article-title":"The m6A demethylase ALKBH5 promotes tumor progression by inhibiting RIG-I expression and interferon alpha production through the IKK\u03b5\/TBK1\/IRF3 pathway in head and neck squamous cell carcinoma","volume":"21","author":"Jin","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2023.115171_bib81","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41571-022-00601-9","article-title":"Mechanisms regulating PD-L1 expression in cancers and associated opportunities for novel small-molecule therapeutics","volume":"19","author":"Yamaguchi","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biopha.2023.115171_bib82","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.immuni.2018.03.014","article-title":"Regulation and Function of the PD-L1 Checkpoint","volume":"48","author":"Sun","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2023.115171_bib83","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12943-021-01489-2","article-title":"Combination strategies with PD-1\/PD-L1 blockade: current advances and future directions","volume":"21","author":"Yi","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2023.115171_bib84","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41571-021-00473-5","article-title":"PD-L1 as a biomarker of response to immune-checkpoint inhibitors","volume":"18","author":"Doroshow","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biopha.2023.115171_bib85","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2023.115171_bib86","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ccell.2015.03.001","article-title":"Immune checkpoint blockade: a common denominator approach to cancer therapy","volume":"27","author":"Topalian","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biopha.2023.115171_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2022.100850","article-title":"Fusobacterium nucleatum stimulates cell proliferation and promotes PD-L1 expression via IFIT1-related signal in colorectal cancer","volume":"35","author":"Gao","year":"2023","journal-title":"Neoplasia (New York, N.Y.)"},{"key":"10.1016\/j.biopha.2023.115171_bib88","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1158\/0008-5472.CAN-21-1323","article-title":"JNK signaling promotes bladder cancer immune escape by regulating METTL3-mediated m6A modification of PD-L1 mRNA","volume":"82","author":"Ni","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2023.115171_bib89","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1093403","article-title":"Decreased expression of programmed death ligand-l1 by seven in absentia homolog 2 in cholangiocarcinoma enhances T-cell-mediated antitumor activity","volume":"13","author":"Zheng","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2023.115171_bib90","doi-asserted-by":"crossref","first-page":"1004212","DOI":"10.3389\/fonc.2022.1004212","article-title":"LncRNA MALAT1 regulates METTL3-mediated PD-L1 expression and immune infiltrates in pancreatic cancer","volume":"12","author":"Song","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biopha.2023.115171_bib91","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41419-023-05570-0","article-title":"m(6)A-modified circRNA MYO1C participates in the tumor immune surveillance of pancreatic ductal adenocarcinoma through m(6)A\/PD-L1 manner","volume":"14","author":"Guan","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2023.115171_bib92","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/s41420-022-01286-w","article-title":"ALKBH5 promotes PD-L1-mediated immune escape through m6A modification of ZDHHC3 in glioma","volume":"8","author":"Tang","year":"2022","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.biopha.2023.115171_bib93","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1136\/gutjnl-2022-326928","article-title":"Methionine deficiency facilitates antitumour immunity by altering m(6)A methylation of immune checkpoint transcripts","volume":"72","author":"Li","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.biopha.2023.115171_bib94","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41423-021-00727-3","article-title":"The therapeutic implications of immunosuppressive tumor aerobic glycolysis","volume":"19","author":"Reinfeld","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.biopha.2023.115171_bib95","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1476-4598-12-152","article-title":"Tumor glycolysis as a target for cancer therapy: progress and prospects","volume":"12","author":"Ganapathy-Kanniappan","year":"2013","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2023.115171_bib96","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s13046-020-01765-x","article-title":"Glycometabolic rearrangements--aerobic glycolysis in pancreatic cancer: causes, characteristics and clinical applications","volume":"39","author":"Cao","year":"2020","journal-title":"J. Exp. Clin. Cancer Res.: CR"},{"key":"10.1016\/j.biopha.2023.115171_bib97","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00018-015-2070-4","article-title":"Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression","volume":"73","author":"Li","year":"2016","journal-title":"Cell. Mol. life Sci.: CMLS"},{"key":"10.1016\/j.biopha.2023.115171_bib98","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nrc1478","article-title":"Why do cancers have high aerobic glycolysis","volume":"4","author":"Gatenby","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2023.115171_bib99","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Sci. (N. Y., N. Y. )"},{"key":"10.1016\/j.biopha.2023.115171_bib100","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13046-020-01629-4","article-title":"Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma","volume":"39","author":"Feng","year":"2020","journal-title":"J. Exp. Clin. Cancer Res.: CR"},{"key":"10.1016\/j.biopha.2023.115171_bib101","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13400","article-title":"Non-SMC condensin I complex subunit H participates in anti-programmed cell death-1 resistance of clear cell renal cell carcinomas","author":"Chen","year":"2023","journal-title":"Cell Prolif."},{"key":"10.1016\/j.biopha.2023.115171_bib102","article-title":"m(6) A Reader YTHDF1-targeting engineered small extracellular vesicles for gastric cancer therapy via epigenetic and immune regulation","volume":"35","author":"You","year":"2023","journal-title":"Adv. Mater. (Deerfield Beach, Fla.)"},{"key":"10.1016\/j.biopha.2023.115171_bib103","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41467-022-35710-7","article-title":"Tumor-intrinsic YTHDF1 drives immune evasion and resistance to immune checkpoint inhibitors via promoting MHC-I degradation","volume":"14","author":"Lin","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2023.115171_bib104","doi-asserted-by":"crossref","first-page":"5876","DOI":"10.1158\/0008-5472.CAN-21-1456","article-title":"ALKBH5 facilitates hypoxia-induced paraspeckle assembly and IL8 secretion to generate an immunosuppressive tumor microenvironment","volume":"81","author":"Dong","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2023.115171_bib105","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210279","article-title":"The RNA m6A reader YTHDF2 controls NK cell antitumor and antiviral immunity","volume":"218","author":"Ma","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biopha.2023.115171_bib106","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1053\/j.gastro.2021.08.003","article-title":"Enterotoxigenic bacteroidesfragilis promotes intestinal inflammation and malignancy by inhibiting exosome-packaged miR-149-3p","volume":"161","author":"Cao","year":"2021","journal-title":"Gastroenterology"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223009629?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223009629?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T07:30:46Z","timestamp":1777879846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223009629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":106,"alternative-id":["S0753332223009629"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115171","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N6-methyladenosine modification: an important player in the tumor immune microenvironment","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115171","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115171"}}